Exchange
ASX
Every company in the roster listed on ASX.
Research
Compare financial metrics on this exchange
Research adds market cap, cash, runway and annualized R&D metrics with metric-specific sorting.
Views
3 of 3 companies
| Company | Pipeline | Most advanced | Next readout |
|---|---|---|---|
 Mayne PharmaMYX · ASX | 2 assets: 2 approved | Approved assets only | None on record |
 Actinogen Medical (ASX: ACW)ACW · ASX | 1 asset: 1 Ph 3 | EmestedastatPhase 2/3 · Alzheimer's DiseasePartial signal | None on record |
 AdAlta1AD · ASX | 1 asset: 1 Ph 1 | AD-214Phase 1 · Chronic Kidney DiseasePartial signal | None on record |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov).